DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
2.076
-0.094 (-4.33%)
Nov 16, 2026, 4:00 PM EST - Market closed

DNA X Statistics

Total Valuation

DNA X has a market cap or net worth of $3.09 million. The enterprise value is $4.59 million.

Market Cap3.09M
Enterprise Value 4.59M

Important Dates

The next estimated earnings date is Friday, November 27, 2026, before market open.

Earnings Date Nov 27, 2026
Ex-Dividend Date n/a

Share Statistics

DNA X has 1.49 million shares outstanding. The number of shares has increased by 233.44% in one year.

Current Share Class 1.49M
Shares Outstanding 1.49M
Shares Change (YoY) +233.44%
Shares Change (QoQ) +6.79%
Owned by Insiders (%) 10.15%
Owned by Institutions (%) 9.13%
Float 1.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 0.04
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.57

Current Ratio 0.57
Quick Ratio 0.42
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.75

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -18.66%
Return on Invested Capital (ROIC) -275.50%
Return on Capital Employed (ROCE) 959.02%
Weighted Average Cost of Capital (WACC) 26.12%
Revenue Per Employee n/a
Profits Per Employee -$2.14M
Employee Count4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -78.75% in the last 52 weeks. The beta is 1.83, so DNA X's price volatility has been higher than the market average.

Beta (5Y) 1.83
52-Week Price Change -78.75%
50-Day Moving Average 3.22
200-Day Moving Average 3.99
Relative Strength Index (RSI) 29.76
Average Volume (20 Days) 14,527

Short Selling Information

The latest short interest is 9,830, so 0.66% of the outstanding shares have been sold short.

Short Interest 9,830
Short Previous Month 10,815
Short % of Shares Out 0.66%
Short % of Float 0.98%
Short Ratio (days to cover) 0.91

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.06M
Pretax Income -10.30M
Net Income -8.55M
EBITDA -3.48M
EBIT -6.06M
Earnings Per Share (EPS) -$7.35
Full Income Statement

Balance Sheet

The company has $900,000 in cash and $2.40 million in debt, with a net cash position of -$1.50 million or -$1.01 per share.

Cash & Cash Equivalents 900,000
Total Debt 2.40M
Net Cash -1.50M
Net Cash Per Share -$1.01
Equity (Book Value) -1.23M
Book Value Per Share -0.83
Working Capital -2.23M
Full Balance Sheet

Cash Flow

Operating Cash Flow -14.51M
Capital Expenditures n/a
Depreciation & Amortization 2.58M
Net Borrowing 5.42M
Free Cash Flow -14.51M
FCF Per Share -$9.75
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DNA X does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -233.44%
Shareholder Yield -233.44%
Earnings Yield -353.89%
FCF Yield -449.13%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 27, 2025. It was a reverse split with a ratio of 1:18.

Last Split Date Oct 27, 2025
Split Type Reverse
Split Ratio 1:18

Scores

Altman Z-Score n/a
Piotroski F-Score n/a